Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-13 8:07 pm Sale | 13G | Maravai LifeSciences Holdings, Inc. MRVI | Select Equity Group L.P. | 2,524,793 1.9% | -8,996,782 (-78.09%) | View |
| 2023-02-09 11:25 am Sale | 13G | Maravai LifeSciences Holdings, Inc. MRVI | VANGUARD GROUP INC | 10,389,979 7.9% | -143,630 (-1.36%) | View |
| 2023-02-08 4:07 pm Sale | 13G | Maravai LifeSciences Holdings, Inc. MRVI | MASSACHUSETTS FINANCIAL SERVICES CO | 13,047,960 9.9% | -884,724 (-6.35%) | View |
| 2022-11-10 4:41 pm Sale | 13G | Maravai LifeSciences Holdings, Inc. MRVI | Select Equity Group L.P. | 11,521,575 8.8% | -9,020,928 (-43.91%) | View |
| 2022-09-06 4:00 pm Unchanged | 13G | Maravai LifeSciences Holdings, Inc. MRVI | MASSACHUSETTS FINANCIAL SERVICES CO | 13,932,684 10.6% | 0 (Unchanged) | View |
| 2022-09-06 2:37 pm Purchase | 13G | Maravai LifeSciences Holdings, Inc. MRVI | MASSACHUSETTS FINANCIAL SERVICES CO | 13,932,684 10.6% | 5,929,663 (+74.09%) | View |
| 2022-07-11 08:49 am Sale | 13G | Maravai LifeSciences Holdings, Inc. MRVI | FMR LLC | 4,007,903 3.046% | -8,699,742 (-68.46%) | View |
| 2022-02-14 10:11 am Sale | 13G | Maravai LifeSciences Holdings, Inc. MRVI | D1 Capital Partners L.P. | 0 0% | -5,930,000 (Position Closed) | View |
| 2022-02-11 5:38 pm Purchase | 13G | Maravai LifeSciences Holdings, Inc. MRVI | Select Equity Group L.P. | 20,542,503 15.6% | 5,607,666 (+37.55%) | View |
| 2022-02-11 4:16 pm Sale | 13G | Maravai LifeSciences Holdings, Inc. MRVI | MARAVAI LIFE SCIENCES HOLDINGS 2 LLC | 145,350,229 56.97% | -43,270,415 (-22.94%) | View |
| 2022-02-10 08:22 am Purchase | 13G | Maravai LifeSciences Holdings, Inc. MRVI | VANGUARD GROUP INC | 10,533,609 8.01% | 5,820,157 (+123.48%) | View |
| 2022-02-09 09:22 am Purchase | 13G | Maravai LifeSciences Holdings, Inc. MRVI | FMR LLC | 12,707,645 9.666% | 3,004,403 (+30.96%) | View |
| 2022-02-02 12:46 pm Purchase | 13G | Maravai LifeSciences Holdings, Inc. MRVI | MASSACHUSETTS FINANCIAL SERVICES CO | 8,003,021 6.1% | 8,003,021 (New Position) | View |
| 2021-11-09 5:07 pm Purchase | 13G | Maravai LifeSciences Holdings, Inc. MRVI | Select Equity Group L.P. | 14,934,837 11.4% | 14,934,837 (New Position) | View |
| 2021-04-12 1:05 pm Purchase | 13G | Maravai LifeSciences Holdings, Inc. MRVI | FMR LLC | 9,703,242 10.039% | 3,996,681 (+70.04%) | View |
| 2021-02-16 09:39 am Purchase | 13G | Maravai LifeSciences Holdings, Inc. MRVI | D1 Capital Partners L.P. | 5,930,000 6.1% | 5,930,000 (New Position) | View |
| 2021-02-11 4:00 pm Purchase | 13G | Maravai LifeSciences Holdings, Inc. MRVI | MARAVAI LIFE SCIENCES HOLDINGS 2 LLC | 188,620,644 73.2% | 188,620,644 (New Position) | View |
| 2021-02-10 11:22 am Purchase | 13G | Maravai LifeSciences Holdings, Inc. MRVI | VANGUARD GROUP INC | 4,713,452 5.3% | 4,713,452 (New Position) | View |
| 2021-02-08 10:27 am Purchase | 13G | Maravai LifeSciences Holdings, Inc. MRVI | FMR LLC | 5,706,561 6.414% | 5,706,561 (New Position) | View |